To assess whether relative polygenic risk was associated with regional neuropathological traits across the ALS-FTD spectrum, the difference between C2 FTLD-TDP risk and C1 ALS risk was tested for association with the burden of TDP-43 pathology across brain regions. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.